Shanghai United PharmaTech

Shanghai United PharmaTech is a specialty pharmaceutical company and CDMO focused on the development and large-scale manufacturing of high-end generic drugs for the global market. The company specializes in complex drug delivery systems, particularly oral solid dosage forms such as sustained-release, controlled-release, and multi-layer tablets. As a core subsidiary of Novast Holdings, it operates facilities that are regularly inspected and approved by the US FDA, enabling the export of numerous ANDA products to the United States. Their service offerings include formulation development, analytical testing, and commercial-scale manufacturing for international pharmaceutical partners. The company is a key player in bridging the quality gap between Chinese domestic manufacturing and international standards.